Clinical utility in maximizing CD34+ cell count in stem cell grafts

被引：13

作者：

Burt, RK ^{[1
]}

机构：

[1] Northwestern Univ, Chicago, IL 60612 USA

来源：

STEM CELLS | 1999年 / 17卷 / 06期

关键词：

D O I：

10.1002/stem.170373

中图分类号：

Q813 [细胞工程];

学科分类号：

摘要：

[No abstract available]

引用

页码：373 / 376

页数：4

共 22 条

[1] Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype [J].

Aversa, F ;

Tabilio, A ;

Velardi, A ;

Cunningham, I ;

Terenzi, A ;

Falzetti, F ;

Ruggeri, L ;

Barbabietola, G ;

Aristei, C ;

Latini, P ;

Reisner, Y ;

Martelli, MF .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (17) :1186-1193

[2] MEGADOSE OF T-CELL-DEPLETED BONE-MARROW OVERCOMES MHC BARRIERS IN SUBLETHALLY IRRADIATED MICE [J].

BACHARLUSTIG, E ;

RACHAMIM, N ;

LI, HW ;

LAN, FS ;

REISNER, Y .

NATURE MEDICINE, 1995, 1 (12) :1268-1273

[3] TRANSPLANTATION OF ALLOGENEIC PERIPHERAL-BLOOD STEM-CELLS MOBILIZED BY RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR [J].

BENSINGER, WI ;

WEAVER, CH ;

APPELBAUM, FR ;

ROWLEY, S ;

DEMIRER, T ;

SANDERS, J ;

STORB, R ;

BUCKNER, CD .

BLOOD, 1995, 85 (06) :1655-1658

[4] Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: A retrospective comparison with marrow transplantation [J].

Bensinger, WI ;

Clift, R ;

Martin, P ;

Appelbaum, FR ;

Demirer, T ;

Gooley, T ;

Lilleby, K ;

Rowley, S ;

Sanders, J ;

Storb, R ;

Buckner, CD .

BLOOD, 1996, 88 (07) :2794-2800

[5] HIGH-DOSE ETOPOSIDE, CYCLOPHOSPHAMIDE, AND TOTAL-BODY IRRADIATION WITH ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH ACUTE MYELOID-LEUKEMIA IN UNTREATED FIRST RELAPSE - A STUDY BY THE NORTH-AMERICAN MARROW TRANSPLANT GROUP [J].

BROWN, RA ;

WOLFF, SN ;

FAY, JW ;

PINEIRO, L ;

COLLINS, RH ;

LYNCH, JP ;

STEVENS, D ;

GREER, J ;

HERZIG, RH ;

HERZIG, GP .

BLOOD, 1995, 85 (05) :1391-1395

[6] Stem cell component therapy: supplementation of unmanipulated marrow with CD34 enriched peripheral blood stem cells [J].

Burt, RK ;

Kuzel, TM ;

Fishman, M ;

Brush, M ;

Villa, M ;

Welles, C ;

Rosen, S ;

Traynor, AE .

BONE MARROW TRANSPLANTATION, 1999, 23 (04) :381-386

[7] SUBSETS OF CD34(+) CELLS AND RAPID HEMATOPOIETIC RECOVERY AFTER PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION [J].

DERCKSEN, MW ;

RODENHUIS, S ;

DIRKSON, MKA ;

SCHAASBERG, WP ;

BAARS, JW ;

VANDERWALL, E ;

SLAPERCORTENBACH, ICM ;

PINEDO, HM ;

VONDEMBORNE, AEGK ;

VANDERSCHOOT, CE ;

GERRITSEN, WR .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) :1922-1932

[8] Relationship of CD34(+) cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation [J].

Kiss, JE ;

Rybka, WB ;

Winkelstein, A ;

deMagalhaesSilverman, M ;

Lister, J ;

DAndrea, P ;

Ball, ED .

BONE MARROW TRANSPLANTATION, 1997, 19 (04) :303-310

[9] ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION FOR REFRACTORY LEUKEMIA AND LYMPHOMA - POTENTIAL ADVANTAGE OF BLOOD OVER MARROW ALLOGRAFTS [J].

KORBLING, M ;

PRZEPIORKA, D ;

HUH, YO ;

ENGEL, H ;

VANBESIEN, K ;

GIRALT, S ;

ANDERSSON, B ;

KLEINE, HD ;

SEONG, D ;

DEISSEROTH, AB ;

ANDREEFF, M ;

CHAMPLIN, R .

BLOOD, 1995, 85 (06) :1659-1665

[10]

KORBLING M, 1997, BONE MARROW TRANS S1, V19, pS72

← 1 2 3 →